Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
260.5 USD | -0.20% |
|
+3.78% | +36.10% |
Jul. 03 | Jerome Powell did it again | ![]() |
Jul. 03 | JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.10% | 32.95B | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B | |
-8.55% | 11.14B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Transcript : Alnylam Pharmaceuticals, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-11-2016 10